Charles Schwab’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$432M Sell
1,127,336
-16,950
-1% -$6.49M 0.07% 225
2025
Q1
$395M Sell
1,144,286
-4,757
-0.4% -$1.64M 0.07% 227
2024
Q4
$345M Buy
1,149,043
+6,590
+0.6% +$1.98M 0.06% 248
2024
Q3
$464M Sell
1,142,453
-25,408
-2% -$10.3M 0.09% 193
2024
Q2
$375M Buy
1,167,861
+8,394
+0.7% +$2.7M 0.07% 234
2024
Q1
$387M Buy
1,159,467
+32,917
+3% +$11M 0.09% 199
2023
Q4
$305M Buy
1,126,550
+6,407
+0.6% +$1.73M 0.08% 228
2023
Q3
$276M Sell
1,120,143
-6,925
-0.6% -$1.7M 0.08% 220
2023
Q2
$342M Sell
1,127,068
-33,089
-3% -$10M 0.1% 182
2023
Q1
$306M Buy
1,160,157
+13,613
+1% +$3.59M 0.09% 192
2022
Q4
$275M Buy
1,146,544
+9,133
+0.8% +$2.19M 0.09% 213
2022
Q3
$209M Sell
1,137,411
-24,135
-2% -$4.44M 0.07% 237
2022
Q2
$195M Sell
1,161,546
-55,473
-5% -$9.32M 0.07% 265
2022
Q1
$305M Buy
1,217,019
+31,199
+3% +$7.82M 0.09% 200
2021
Q4
$305M Sell
1,185,820
-19,833
-2% -$5.1M 0.09% 196
2021
Q3
$293M Sell
1,205,653
-179,311
-13% -$43.5M 0.1% 185
2021
Q2
$286M Buy
1,384,964
+5,006
+0.4% +$1.03M 0.1% 186
2021
Q1
$260M Buy
1,379,958
+51,309
+4% +$9.66M 0.1% 185
2020
Q4
$219M Buy
1,328,649
+3,282
+0.2% +$540K 0.09% 209
2020
Q3
$165M Buy
1,325,367
+22,217
+2% +$2.77M 0.08% 233
2020
Q2
$126M Sell
1,303,150
-185,745
-12% -$18M 0.06% 285
2020
Q1
$134M Buy
1,488,895
+3,723
+0.3% +$335K 0.08% 242
2019
Q4
$220M Sell
1,485,172
-29,562
-2% -$4.37M 0.12% 165
2019
Q3
$182M Buy
1,514,734
+18,169
+1% +$2.19M 0.11% 186
2019
Q2
$202M Sell
1,496,565
-67,299
-4% -$9.1M 0.12% 156
2019
Q1
$204M Buy
1,563,864
+194,524
+14% +$25.4M 0.13% 144
2018
Q4
$170M Buy
1,369,340
+177,075
+15% +$22M 0.13% 144
2018
Q3
$166M Sell
1,192,265
-30,078
-2% -$4.18M 0.11% 165
2018
Q2
$125M Buy
1,222,343
+64,426
+6% +$6.61M 0.09% 203
2018
Q1
$112M Buy
1,157,917
+31,209
+3% +$3.03M 0.09% 218
2017
Q4
$99M Buy
1,126,708
+8,623
+0.8% +$757K 0.08% 241
2017
Q3
$89M Buy
1,118,085
+51,727
+5% +$4.12M 0.08% 238
2017
Q2
$93M Buy
1,066,358
+12,797
+1% +$1.12M 0.09% 227
2017
Q1
$93.8M Sell
1,053,561
-30,231
-3% -$2.69M 0.09% 206
2016
Q4
$80.2M Buy
1,083,792
+52,825
+5% +$3.91M 0.09% 222
2016
Q3
$78M Sell
1,030,967
-6,589
-0.6% -$498K 0.09% 222
2016
Q2
$79.9M Buy
1,037,556
+15,333
+1% +$1.18M 0.1% 203
2016
Q1
$79.8M Sell
1,022,223
-5,282
-0.5% -$412K 0.1% 180
2015
Q4
$69.5M Buy
1,027,505
+33,743
+3% +$2.28M 0.09% 205
2015
Q3
$76.9M Buy
993,762
+50,337
+5% +$3.89M 0.11% 174
2015
Q2
$85.6M Buy
943,425
+18,849
+2% +$1.71M 0.12% 168
2015
Q1
$69.6M Buy
924,576
+409,902
+80% +$30.8M 0.1% 203
2014
Q4
$37.8M Buy
514,674
+33,886
+7% +$2.49M 0.06% 328
2014
Q3
$33.9M Buy
480,788
+44,931
+10% +$3.17M 0.06% 323
2014
Q2
$24.6M Buy
435,857
+23,139
+6% +$1.3M 0.04% 418
2014
Q1
$21.7M Buy
412,718
+48,973
+13% +$2.57M 0.04% 436
2013
Q4
$17.4M Buy
363,745
+73,563
+25% +$3.51M 0.03% 476
2013
Q3
$12.9M Buy
290,182
+38,351
+15% +$1.71M 0.03% 526
2013
Q2
$9.3M Buy
+251,831
New +$9.3M 0.02% 613